BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
Sep. 13, 2016
View Archived Issues
Alere, Abbott agree to mediation, not much else in contested merger nuptials
A court battle between Alere Inc. and its potential acquirer Abbott Labs could be inching towards a resolution. The two sides agreed last week to work with a mediator to resolve the dispute, which has landed in the Delaware Chancery Court.
Read More
Sanofi, Verily Life Sciences invest $500M for their Onduo diabetes-focused collaboration
Read More
BSX's Craig Thompson shares perspectives on the interventional cardiology market
Read More
Mylan has invested $1B to raise awareness of need for Epipen
Read More
Attorney says FDA faces losing court battles over tissue therapy regulation
Read More
Other news to note
Read More
Appointments and advancements
Read More
Financings
Read More
Product briefs
Read More
MDD's Cardiology Extra
Read More
